NCT00002194View on ClinicalTrials.gov

An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Erythromycin

DRUG

Nevirapine

DRUG

Clarithromycin

Trial Locations (1)

331813405

South Florida Bioavailability Clinic, Miami

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00002194 - An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4. | Biotech Hunter | Biotech Hunter